The largest database of trusted experimental protocols

376 protocols using p iκbα

1

Osteoarthritis Chondrocyte Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total lysates of human OA chondrocytes were prepared using RIPA buffer (Biosesang, Gyeonggi-do, Korea). Primary antibodies against MMP3, MMP13 (1:1000 dilution, Cell Signaling Technology, Danvers, MA, USA), COL2A1 (1:1000 dilution, Abcam), ACAN (1:500 dilution, Invitrogen), p38, p-p38, ERK, p-ERK, JNK, p-JNK, p65, p-p65, IκBα, p-IκBα, or β-actin (1:1000 dilution, Cell Signaling Technology) and appropriate HRP-conjugated secondary antibodies (1:2000 dilution, Bethyl) were used. Enhanced chemiluminescence (ECL) detection kit (Thermo Fisher Scientific) was used to detect for specific bands. Chemiluminescent signals were analyzed on a ChemiDoc XRS gel imaging system (Bio-Rad Laboratories, Hercules, CA, USA), and intensity of specific bands was quantified using Image J software (NIH, MD, USA).
+ Open protocol
+ Expand
2

Immunoblotting Techniques for Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against Myc-tag, G3BP1, RIG-I, p-P65, P65, p-IRF3, IRF3, p-IκBα, and IκBα were obtained from Cell Signaling Technology; anti-Flag, anti-HA, and anti-β-actin were from Sigma; horseradish peroxidase (HRP)-conjugated anti-mouse IgG and anti-rabbit IgG were from Thermo; HRP-conjugated anti-goat IgG was from Zhong Shan Jin Qiao; MG132 and 3-MA were from Sigma; RNF125 and K48-Ub were from Abcam; Ub was from Santa Cruz Biotechnology; 5´ppp-dsRNA was from InvivoGen; EZ-link Psoralen-PEG3-Biotin and Streptavidin agarose resin were from Thermo Fisher. SeV and VSV-GFP were described previously26 (link),27 (link). The cultivation of human embryonic kidney (HEK) 293 T cells have been described previously28 (link).
+ Open protocol
+ Expand
3

Osteoclastogenesis Regulation by MSNs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMMs were seeded into six-well plates at the appropriate density and stimulated with 30 ng/mL M-CSF and 50 ng/mL RANKL plus either MSNs (16 or 64 μg/mL) or MSNs-ISL (16 or 64 μg/mL) for 30 min or 24 h. The cells were washed twice with ice-cold PBS and then lysed using RIPA lysate containing protease and phosphatase inhibitor. Protein content was determined using a BCA protein quantification kit (Beyotime Inc, Shanghai, China) following the manufacturer's protocol. Total proteins were transferred onto a polyvinylidene difluoride membrane, blocked in non-fat milk for 1 h at room temperature, and incubated overnight with the specific primary antibodies at 4 °C. GAPDH served as the protein internal standard and the standard for quantifying protein expression. The specific primary antibodies used were p38, p-p38, extracellular signal-regulated protein kinase (ERK), p-ERK, nuclear factor-κB (NF-κB) p65, p NF-κB p65, inhibitor of κBα (IκBα), p-IκBα, GAPDH (Cell Signaling Technology, Danvers, MA), c-Jun N-terminal kinase (JNK), p-JNK, tumor necrosis factor receptor-associated factor 6 (TRAF6), and nuclear factor of activated T cells (NFATc1; Santa Cruz Biotechnology, Santa Cruz, CA). The gray values of the band were quantified.
+ Open protocol
+ Expand
4

Molecular Mechanisms in Stroke Recovery

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 24 h after recanalization, the cortex was obtained for immunoblotting as previously described. Proteins obtained from the peri-infarct cortex were subjected to sodium-dodecyl sulfate polyacrylamide gel electrophoresis and electrically transferred to a polyvinylidene difluoride membrane before being incubated with specific antibodies. Primary antibodies against the following mediators were used: TNF-α, cyclooxygenase 2 (Cox-2), inducible nitric oxide synthase (iNOS), IL-6, phospho-NF-κB p65 (p-p65), phospho-inhibitory subunit of NF-κB-α (p-IκBα), p-c-Jun, phosphorylated c-Jun-N-terminal kinase (p-JNK), phosphorylated mitogen-activated protein kinase (MAPK) p38 (p-p38), β-actin (1:1000; all from Cell Signaling Technology, Danvers, MA, USA) and IL-1β (1:1000; Wanleibio, Shanghai, China). The membranes were incubated for 1 h with the appropriate secondary antibody (anti-rabbit IgG, anti-mouse IgG; 1:5000; Yeasen). The antibodies were visualized by enhanced chemiluminescence (ECL Plus; Beyotime Biotechnology). ImageJ (NIH, Bethesda, MD, USA) was used to analyze the band intensity. For individual samples, each value was normalized to that of β-actin.
+ Open protocol
+ Expand
5

Signaling Pathway Inhibitors in Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
FTY720 was obtained from Cayman Chemical. The primary antibodies including caspase-3, P-IκBα, extracellular signal-regulated kinase (ERK)1/2, and protein kinase B (AKT) were purchased from Cell Signaling Technology. Vulcanized polyethylene (VPC)23019, polyether diols (PD)98059, and Wortmannin were obtained from Gibco Company. The ELISA kits were purchased from R&D Company (Minneapolis, Minn).
+ Open protocol
+ Expand
6

Protein Expression Analysis in Colon and Neutrophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Colon tissues or neutrophils were homogenized in RIPA buffer with protease inhibitor buffer (1:100) and phosphatase inhibitors (1:50). The protein concentration was determined with a BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA). Equal amounts of protein were separated by SDS–PAGE and transferred onto nitrocellulose membranes. After being blocked with 5% nonfat milk in TBST, the membranes were incubated at 4°C overnight with rabbit polyclonal antibodies against α-Actinin (1:5,000), ZO-1 (1:1,000), Claudin-1 (1:800) and IκBα (1:1,000) (Proteintech Group), p-IκBα (1:1,000), NF-κB (p65) (1:1,000), p-NF-κB (p65) (1:1,000) (Cell Signaling Technology), and β-actin (1:5,000) (Santa Cruz Biotechnology). Then, the nitrocellulose membranes were incubated at room temperature for 1.5 hours with goat anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibodies (1:5,000), which were obtained from ZSGB-BIO, Inc. (Beijing, China). Finally, ImageJ software was used for optical density analysis. And the uncropped and representative images were shown in Supplementary Materials (Figures S2, S3).
+ Open protocol
+ Expand
7

Molecular Mechanisms of Anti-Inflammatory Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide (LPS), monosodium urate (MSU), and colchicine were purchased from Sigma-Aldrich (St. Louis, MO, USA). Neoastilbin (purity ≥ 98%) was purchased from Sichuan Victory Biological Technology Co., Ltd. (Chengdu, China). Fetal bovine serum (FBS) was purchased from Gibco (Scoresby, Australia). Penicillin–streptomycin solution was purchased from HyClone (Logan, UT, USA). Cell Counting Kit-8 (CCK-8) was purchased from Biosharp Life Sciences (Beijing, China). Enzyme-linked immunosorbent assay (ELISA) kits for interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were purchased from MEIMIAN (Shanghai, China). NLRP3, ASC, Caspase-1, NF-κB p-p65, NF-κB p65, p-IKKα, IKKα, p-IκBα, IκBα, β-actin and Histone H3 antibodies were purchased from Cell Signaling Technology (Boston, MA, USA).
+ Open protocol
+ Expand
8

Macrophage Differentiation and Activation Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant murine macrophage colony-stimulating factor (M-CSF) and RANKL were purchased from R&D Systems. Antibodies against p100/p52 (Cat# 4882s) and p-IκBα (Cat# 9246s) were purchased from Cell Signaling, p65 (Cat# sc-372), and RelB (Cat# sc-226) antibodies were from Santa Cruz, and β-actin antibody was purchased from Sigma (Cat# A5441). The compound 5-hydroxy-2-methyl-1,4-naphthoquinone (plumbagin) was purchased from MolPort Inc.
+ Open protocol
+ Expand
9

Investigating MLN4924's Effect on A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells were treated with 1 µmol/L MLN4924 for either 12 h or 24 h. As a control, an equal volume of DMSO was added. Cells from each group were collected, lysed with sodium dodecyl sulfate buffer, and heated at 100 °C for 10 min. Proteins were separated on 10% Bis–Tris polyacrylamide gels by electrophoresis and transferred to polyvinylidene fluoride membranes (Millipore, Bedford, USA). Protein bands were visualized using an enhanced chemiluminescence kit and images were captured using an Amersham Imager 680 (GE Healthcare, IL, USA). Anti-Cullin1 antibody (Abcam, Cambridge, United Kingdom, 75817), anti-phosphorylated nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (p-IκBα) (Cell Signaling Technology, MA, USA, 2859), anti-IκBα (Cell Signaling Technology, MA, USA, 9242) and anti-β-actin antibody (HuaAn, M1210-2) were purchased.
+ Open protocol
+ Expand
10

Quantification of Rho/ROCK/NF-κB Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lung tissues were lysed on ice in radioimmunoprecipitation assay buffer supplemented with 0.1% phenylmethylsulfonyl fluoride. The lysates were centrifuged at 12,000 rpm at 4°C for 10 min, and protein concentration was measured using BCA protein assay kit. The proteins were separated by polyacrylamide gel electrophoresis and transferred onto the membranes. After incubation with primary antibodies for Rho (#2177), ROCK-I (#4035), ROCK-II (#9029), p-IκBα (#2859), IκBα (4812), NF-κB p65 (#8242), and p-NF-κB p65 (#4764) (Cell Signaling, Danvers, MA, U.S.A.) at 4°C overnight, the membranes were incubated with secondary antibodies at room temperature for 2 h. The membranes were washed and developed using ECL kit (Pierce, Rockford, IL, U.S.A.). The band density was estimated using Image.plus5.1 program.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!